Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Natural Alternatives International(NAII)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NAII
09/28/2026: NAII (1-star) is currently NOT-A-BUY. Pass it for now.
Natural Alternatives International, Inc. is a long-standing contract manufacturer and ingredient provider for the global health and wellness industry. The company distinguishes itself through its scientific rigor and proprietary licensing of ingredients like CarnoSyn, which helps provide stable, higher-margin revenue. Its primary investment story centers on its ability to leverage its manufacturing expertise to capture demand from major wellness brands. However, investors must weigh these strengths against risks related to customer concentration, industry-wide pricing pressure, and regulatory sensitivity. This stock may suit value-oriented or income-focused investors who prioritize long-term manufacturing stability and potential dividend returns, while monitoring key contract renewals and R&D successes.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | NAI's growth depends on the cyclical and competitive nature of the supplement market and the adoption of its proprietary ingredients. |
| Momentum investor | Weak fit | The stock often lacks the high-volume, rapid price movement that momentum traders seek. |
| Value investor | Mixed fit | The stock may be attractive if its P/E ratio is low relative to the stability of its manufacturing contracts. |
| Dividend investor | Strong fit | NAI has a history of returning capital through dividends, which may appeal to income-oriented investors. |
| Low-risk investor | Mixed fit | While established, the company is susceptible to market-specific risks and fluctuations in the wellness sector. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock price is subject to fluctuations based on sector sentiment and specific contract wins. |
| Valuation risk | Medium | Investors must ensure the stock price adequately reflects future growth potential in a competitive industry. |
| Competition risk | High | The contract manufacturing space is highly price-sensitive and faces intense competition. |
| Business quality | Medium | NAI has a strong operational history, but profitability is often dependent on large customer contracts. |
| Dividend income | Medium | Dividends are at the discretion of the board and may fluctuate based on earnings. |
| Execution risk | Medium | The company must maintain high-quality manufacturing standards while managing costs effectively. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -45.42% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/28/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 10.67M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 18.1K shares | Beta 0.36 | 52 Weeks Range 1.70 - 4.96 | Updated Date 09/28/2026 |
52 Weeks Range 1.70 - 4.96 | Updated Date 09/28/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.4 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Contract Manufacturing | Custom formulation, production, and packaging of supplement products for third-party brands. | This is the primary revenue engine, relying on long-term relationships with wellness brands. |
| Ingredient Licensing | Royalties from proprietary ingredients like CarnoSyn used by other manufacturers. | This segment provides higher-margin revenue based on the success of patented ingredient science. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 13.61 | Enterprise Value 67.58M | Price to Sales(TTM) 0.08 |
Enterprise Value 67.58M | Price to Sales(TTM) 0.08 | ||
Enterprise Value to Revenue 0.48 | Enterprise Value to EBITDA 74.97 | Shares Outstanding 6.28M | Shares Floating 4.93M |
Shares Outstanding 6.28M | Shares Floating 4.93M | ||
Percent Insiders 21.68 | Percent Institutions 36.34 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Natural Alternatives International
Exchange NASDAQ | Headquarters Carlsbad, CA, United States | ||
IPO Launch date 1987-03-13 | Chairman of the Board & CEO Mr. Mark A. LeDoux J.D. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 293 | Website https://www.nai-online.com |
Full time employees 293 | Website https://www.nai-online.com | ||
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.